ARA-290 (cibinetide) is a synthetic peptide derived from the helix B domain of erythropoietin. It is designed to engage the innate repair receptor without erythropoietic activity and is studied for its effects on tissue-protection and immune signaling. Principal research areas include immune modulation, tissue-protection research, and inflammatory response models. For laboratory research only.